Sign in
Join
Discovery/Preclinical
In vitro
In vivo
Newer Targets
Clinical
Approval
FDA/EMA/Drug Designation
IND
Launch
NDA
Phase I
Phase II
Phase III
Phase IV
Recall
Commercial
Acquisitions
Conference/Award
Deals
Financial
Lawsuits/Bankruptcy
Lay off/Spin-off/Appointments
Merger
Patent
Pricing
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Sign up
Welcome!
Register for an account
your email
your username
A password will be e-mailed to you.
Password recovery
Recover your password
your email
Search
Sign in / Join
Contact
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Create an account
Create an account
Welcome! Register for an account
your email
your username
A password will be e-mailed to you.
Password recovery
Recover your password
your email
A password will be e-mailed to you.
Discovery/Preclinical
All
In vitro
In vivo
Newer Targets
Newer Targets
Gene therapy/gene editing combo could offer hope for some genetic disorders
Newer Targets
Researchers at Rush University Medical Center Find That Injecting Influenza Vaccines…
Newer Targets
Research Reveals Promising New Avenues for Anemia Treatment
Newer Targets
Novel discovery in gene therapy to treat kidney diseases …
Clinical
All
Approval
FDA/EMA/Drug Designation
IND
Launch
NDA
Phase I
Phase II
Phase III
Phase IV
Recall
Phase I
Atreca Announces First Patient Dosed in Phase 1b Clinical Trial of…
Clinical
Deciphera’s investigational GIST drug ripretinib granted priority review by FDA
Clinical
Eisai complies with FDA request to pull weight-loss drug Belviq from…
Clinical
FDA grants priority review to Bristol-Myers Squibb’s filing for liso-cel in…
Commercial
All
Acquisitions
Conference/Award
Deals
Financial
Lawsuits/Bankruptcy
Lay off/Spin-off/Appointments
Merger
Patent
Pricing
Commercial
Acerus Announces Private Placement and Refinancing Transactions
Commercial
Following Clinical Hold and Trial Setback, Ipsen Takes $728 Million Hit…
Commercial
Indivior Full Year 2019 Results Now Available; Leadership Presentation Today
Deals
Sensorion Announces the Full Conversion of Sofinnova Partners Convertible Bonds Into…
Home
Therapy areas
Immuno-inflammation
Immuno-inflammation
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Immuno-inflammation
AbbVie’s SKYRIZI Now Publicly Reimbursed in Ontario, Alberta, Saskatchewan and Quebec for the Treatment of Moderate to Severe Plaque Psoriasis
Firstwordpharma News
-
February 6, 2020
Immuno-inflammation
Atlantic Healthcare Hosts Key Opinion Leader Discussion on Unmet Medical Need in Ulcerative Colitis and the Advantages of Alicaforsen
Immuno-inflammation
Penn Researchers Identify Cancer Cell Defect Driving Resistance to CAR T Cell Therapy
Immuno-inflammation
Discovery would allow researchers to fine-tune CAR-T activity
Immuno-inflammation
Hansa Biopharma Completes Enrollment in Anti-GBM
Immuno-inflammation
Drug profiling and gene scissors open new avenues in immunotherapy
Firstwordpharma News
-
January 22, 2020
0
Immuno-inflammation
ICER Issues Final Report and Policy Recommendations on JAK Inhibitors for...
Firstwordpharma News
-
January 9, 2020
0
Immuno-inflammation
Durect Drug Fails to Shine in Mid-Stage Plaque Psoriasis Trial
Biospace News
-
January 3, 2020
0
Immuno-inflammation
Incyte’s Graft-Versus-Host Trial Fails to Meet Primary Endpoint
Biospace News
-
January 3, 2020
0
Immuno-inflammation
Durect scraps development of DUR-928 for psoriasis after mid-stage study failure
Firstwordpharma News
-
January 2, 2020
0
1
2
3
...
7
Page 1 of 7
- Advertisement -
MOST POPULAR
Auris Medical Announces Closing of Two US Patent Acquisitions Related to...
May 15, 2019
Seattle Genetics & Astellas Report Positive Urothelial Cancer Study
March 28, 2019
Novel discovery in gene therapy to treat kidney diseases ...
January 2, 2020
Onxeo Enters Clinical Research Agreement with Gustave Roussy to Conduct Clinical...
January 29, 2020
Load more
HOT NEWS
Commercial
TerrAscend to Present at 2019 GMP Securities Cannabis Conference
Others
Sound Pharmaceuticals announces completion of patient enrollment in the Phase 2b...
Commercial
Principia Biopharma Reports Third Quarter Financial Results
Commercial
Hansa Biopharma to Host Conference Call to Provide Interim Results for...
